ClinicalTrials.Veeva

Menu
C

Chrysalis Clinical Research | St. George, UT

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Sugar
Insulin icodec
RO7795081
Semaglutide
Tirzepatide
Maridebart Cafraglutide
NNC0165-1875
LY3298176
CT-388
Dapagliflozin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 27 total trials

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

The study is testing UBT251 in participants with type 2 diabetes. The purpose of this clinical study is to find out if UBT251 is effective and safe f...

Enrolling
Diabetes Mellitus, Type 2
Drug: UBT251
Drug: Semaglutide Placebo

The purpose of this study is to see how well LY3938577 works and how safe it is compared to degludec in people with type 2 diabetes. Participation in...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Degludec
Drug: LY3938577

The main purpose of this study is to evaluate the efficacy and safety of retatrutide compared to tirzepatide in adults who have obesity. The study wi...

Active, not recruiting
Obesity
Drug: Retatrutide
Drug: Tirzepatide

This multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Obesity
Drug: Placebo
Drug: Maridebart Cafraglutide
Status recently updated

The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with o...

Not yet enrolling
Enrolling
Overweight
Obesity
Drug: Maridebart cafraglutide
Drug: Placebo

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia (HTG). A...

Active, not recruiting
Hypertriglyceridemia
Drug: Placebo
Drug: Plozasiran Injection

Trial sponsors

Novo Nordisk logo
Lilly logo
Amgen logo
Roche logo
Arrowhead Pharmaceuticals logo
Boehringer Ingelheim logo
C
G
M
Perrigo logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems